What is TKL Research?
Founded in 1944 and headquartered in Fair Lawn, New Jersey, TKL Research operates as a full-service clinical research organization. The company provides comprehensive services to a diverse clientele, including pharmaceutical firms, biotechnology innovators, medical device manufacturers, and consumer healthcare product developers. Its extensive history and broad operational scope position it as a significant entity within the clinical research landscape, facilitating the development and validation of new healthcare solutions.
How much funding has TKL Research raised?
TKL Research has raised a total of $2.6M across 2 funding rounds:
Debt
$1M
Debt
$1.6M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.6M led by PPP
What's next for TKL Research?
The recent major strategic investment signals a pivotal moment for TKL Research, likely enabling accelerated growth and the expansion of its service offerings. This backing, part of its substantial $2.6M in financing, suggests a strategic focus on enhancing its capabilities in clinical trial management, data analysis, and regulatory support. The company is poised to leverage this capital to further solidify its market position and pursue new opportunities in an evolving healthcare ecosystem.
See full TKL Research company page
